https://www.sciencedaily.com/news/health_medicine/today's_healthcare/ Healthcare. Stay abreast of changes in medical procedures, health insurance and managed care. Understand new healthcare options. en-us Tue, 21 Apr 2026 00:12:28 EDT Tue, 21 Apr 2026 00:12:28 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/today's_healthcare/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260417225020.htm Engineers at Northwestern University have taken a striking leap toward merging machines with the human brain by printing artificial neurons that can actually communicate with real ones. These flexible, low-cost devices generate lifelike electrical signals capable of activating living brain cells, a breakthrough demonstrated in mouse brain tissue. Sat, 18 Apr 2026 03:32:36 EDT https://www.sciencedaily.com/releases/2026/04/260417225020.htm https://www.sciencedaily.com/releases/2026/04/260416071953.htm Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers. Fri, 17 Apr 2026 07:44:05 EDT https://www.sciencedaily.com/releases/2026/04/260416071953.htm https://www.sciencedaily.com/releases/2026/04/260416071947.htm A rogue set of “zombie” immune cells may be driving aging and fatty liver disease by flooding tissues with inflammation. Researchers found these cells accumulate with age and high cholesterol—and can make up most of the liver’s immune cells in older mice. When scientists removed them, liver damage was dramatically reversed, even without diet changes. Thu, 16 Apr 2026 07:59:44 EDT https://www.sciencedaily.com/releases/2026/04/260416071947.htm https://www.sciencedaily.com/releases/2026/04/260416025024.htm New research suggests that aiming for a lower blood pressure target may deliver bigger heart health benefits than previously thought. Using large datasets and simulation models, scientists found that keeping systolic blood pressure below 120 mm Hg could reduce the risk of heart attack, stroke, and heart failure more than higher targets. Thu, 16 Apr 2026 02:56:00 EDT https://www.sciencedaily.com/releases/2026/04/260416025024.htm https://www.sciencedaily.com/releases/2026/04/260415043617.htm A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some widely used medications—including antidepressants and certain antidiarrheal drugs—were linked to a small but noticeable increase in the risk of death over time. Thu, 16 Apr 2026 05:19:45 EDT https://www.sciencedaily.com/releases/2026/04/260415043617.htm https://www.sciencedaily.com/releases/2026/04/260414075650.htm Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, researchers created powerful human-like antibodies that block the virus from attaching to and entering immune cells. One of these antibodies completely prevented infection in lab models with human immune systems, marking a breakthrough after years of difficulty tackling EBV’s ability to invade nearly all B cells. Wed, 15 Apr 2026 03:26:50 EDT https://www.sciencedaily.com/releases/2026/04/260414075650.htm https://www.sciencedaily.com/releases/2026/04/260413043129.htm New research reveals that obesity affects men and women in surprisingly different ways. Men are more likely to develop harmful abdominal fat and signs of liver stress, while women show higher inflammation and cholesterol levels. These differences could help explain why health risks vary between sexes. Scientists say this could lead to more tailored treatments for obesity. Mon, 13 Apr 2026 09:29:20 EDT https://www.sciencedaily.com/releases/2026/04/260413043129.htm https://www.sciencedaily.com/releases/2026/04/260411022035.htm A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control. Mon, 13 Apr 2026 00:20:02 EDT https://www.sciencedaily.com/releases/2026/04/260411022035.htm https://www.sciencedaily.com/releases/2026/04/260411022029.htm A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly. Sun, 12 Apr 2026 08:58:54 EDT https://www.sciencedaily.com/releases/2026/04/260411022029.htm https://www.sciencedaily.com/releases/2026/04/260411022023.htm Putting on weight earlier in life may be more dangerous than previously thought. Researchers found that early adulthood obesity significantly raises the risk of premature death, especially from major diseases like heart disease and diabetes. The longer the body carries excess weight, the greater the damage appears to be. Interestingly, cancer risk in women didn’t follow this pattern, suggesting other biological factors are at play. Sat, 11 Apr 2026 09:54:18 EDT https://www.sciencedaily.com/releases/2026/04/260411022023.htm https://www.sciencedaily.com/releases/2026/04/260408225944.htm A new study reveals that gut bacteria may play a key role in triggering ALS and frontotemporal dementia. Harmful sugars produced by these microbes can spark immune responses that damage the brain. This breakthrough explains why some genetically at-risk people develop the diseases while others don’t. Even more promising, reducing these sugars improved brain health in experiments, hinting at new treatment possibilities. Thu, 09 Apr 2026 06:36:40 EDT https://www.sciencedaily.com/releases/2026/04/260408225944.htm https://www.sciencedaily.com/releases/2026/04/260408225941.htm Scientists are uncovering a surprising connection between autism and ADHD that goes deeper than labels. Instead of diagnoses, it’s the severity of autism-like traits that seems to shape how the brain is wired—even in children who don’t officially have autism. The study found that certain brain networks tied to thinking and social behavior stay unusually connected in kids with stronger autism symptoms, hinting at a different developmental path. Thu, 09 Apr 2026 08:21:49 EDT https://www.sciencedaily.com/releases/2026/04/260408225941.htm https://www.sciencedaily.com/releases/2026/04/260408225934.htm A hidden waste-removal pathway in the brain has finally been caught in action. Using cutting-edge MRI scans, researchers discovered that fluid flows along the middle meningeal artery in a slow, lymphatic-like pattern—very different from blood. This confirms the presence of a previously unknown drainage hub in humans. The finding could transform how scientists approach brain aging, injury, and diseases like Alzheimer’s. Thu, 09 Apr 2026 10:11:49 EDT https://www.sciencedaily.com/releases/2026/04/260408225934.htm https://www.sciencedaily.com/releases/2026/04/260408095346.htm A new survey reveals a striking disconnect in how Americans think about autism research. While nearly everyone agrees that studying the autistic brain is essential, most people are unaware that brain donation after death is a key part of making that research possible. Unlike organ donation, brain donation is a separate process, and widespread confusion remains about how it works, when it must occur, and who can participate. Wed, 08 Apr 2026 22:18:02 EDT https://www.sciencedaily.com/releases/2026/04/260408095346.htm https://www.sciencedaily.com/releases/2026/04/260406192913.htm A single week of intensive meditation and mind-body practices led to measurable changes across the brain and body. Researchers observed improved brain efficiency, boosted immune signaling, and increased natural pain relief chemicals in participants’ blood. The effects even promoted neuron growth and stronger brain connectivity. Surprisingly, the experience mirrored psychedelic-like brain states—without any drugs involved. Tue, 07 Apr 2026 03:56:04 EDT https://www.sciencedaily.com/releases/2026/04/260406192913.htm https://www.sciencedaily.com/releases/2026/04/260404082652.htm Many people think that occasional binge drinking is harmless if they otherwise drink in moderation, but new research suggests that assumption may be dangerously wrong. A large U.S. study found that people with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting about one in three adults, face a much higher risk of serious liver scarring if they engage in heavy drinking even just once a month. Sat, 04 Apr 2026 08:29:44 EDT https://www.sciencedaily.com/releases/2026/04/260404082652.htm https://www.sciencedaily.com/releases/2026/04/260403232124.htm A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t respond to standard treatments. In a large global trial, patients saw their blood pressure drop by nearly 10 mmHg, a meaningful reduction that can significantly lower the risk of heart attack, stroke, and kidney disease. By targeting a hormone that causes the body to retain salt and water, this treatment could offer a much-needed solution for millions struggling with uncontrolled hypertension. Fri, 03 Apr 2026 23:38:49 EDT https://www.sciencedaily.com/releases/2026/04/260403232124.htm https://www.sciencedaily.com/releases/2026/04/260402042803.htm Scientists have discovered a way to make French fries less greasy without ruining their taste. By combining regular frying with microwave heating, they reduce the amount of oil absorbed during cooking. The key lies in pressure inside the food—microwaves help push oil out instead of letting it seep in. The result: faster cooking, lower fat, and fries that can still stay crispy. Thu, 02 Apr 2026 19:15:35 EDT https://www.sciencedaily.com/releases/2026/04/260402042803.htm https://www.sciencedaily.com/releases/2026/04/260402042751.htm A new clinical trial suggests that what people eat could finally offer real relief for Crohn’s disease, a condition that has long lacked clear dietary guidance. Researchers found that a “fasting-mimicking diet” — involving just five days a month of very low-calorie, plant-based meals — led to noticeable improvements in symptoms for most participants. Even more striking, the diet didn’t just make patients feel better; it also reduced key biological markers of inflammation linked to the disease. Fri, 03 Apr 2026 04:55:54 EDT https://www.sciencedaily.com/releases/2026/04/260402042751.htm https://www.sciencedaily.com/releases/2026/04/260402042744.htm Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers, preventing damage to healthy tissue. The system can also deliver multiple drugs at once, potentially overcoming resistance. This marks a step toward medicines that behave more like smart, responsive machines inside the body. Thu, 02 Apr 2026 04:27:44 EDT https://www.sciencedaily.com/releases/2026/04/260402042744.htm https://www.sciencedaily.com/releases/2026/04/260402042740.htm A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of reality. The mutation disrupts a brain circuit involved in flexible decision-making, causing mice to stick with outdated choices even when conditions change. Researchers pinpointed the issue to a key thalamus–prefrontal cortex pathway. By reactivating this circuit, they were able to restore normal behavior—raising hope for future therapies. Fri, 03 Apr 2026 03:10:50 EDT https://www.sciencedaily.com/releases/2026/04/260402042740.htm https://www.sciencedaily.com/releases/2026/04/260401071951.htm Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, researchers discovered that only colorectal tumors consistently host distinct microbial communities—challenging the long-held belief that all cancers have their own microbial signatures. Wed, 01 Apr 2026 23:54:49 EDT https://www.sciencedaily.com/releases/2026/04/260401071951.htm https://www.sciencedaily.com/releases/2026/04/260401071940.htm Hara hachi bu, a traditional Japanese practice of eating until you’re about 80% full, is gaining attention as a simple yet powerful way to improve health and reshape our relationship with food. Rather than promoting strict dieting, it encourages slowing down, tuning into hunger cues, and eating with awareness and gratitude. Research suggests it may help reduce calorie intake, support healthier food choices, and prevent long-term weight gain. Thu, 02 Apr 2026 07:03:26 EDT https://www.sciencedaily.com/releases/2026/04/260401071940.htm https://www.sciencedaily.com/releases/2026/03/260331034337.htm Salt substitutes offer a simple, low-cost way to reduce sodium intake and improve blood pressure, yet very few Americans actually use them—even among those who need them most. A large national analysis spanning nearly two decades found that usage remains surprisingly low and has not improved over time. Researchers say this gap represents a major missed opportunity for preventing heart disease and stroke. Tue, 31 Mar 2026 06:57:40 EDT https://www.sciencedaily.com/releases/2026/03/260331034337.htm https://www.sciencedaily.com/releases/2026/03/260331001107.htm A surprising breakthrough suggests that a drug best known as Viagra could help treat a devastating childhood disease. Researchers found that sildenafil significantly improved symptoms in patients with Leigh syndrome—a rare and often fatal disorder that affects the brain and muscles. In a small study, patients showed stronger muscles, fewer seizures, and better recovery from dangerous metabolic crises, with some experiencing dramatic improvements in mobility and daily life. Tue, 31 Mar 2026 08:33:45 EDT https://www.sciencedaily.com/releases/2026/03/260331001107.htm https://www.sciencedaily.com/releases/2026/03/260331001102.htm Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and efficiently. These “cellular winds” push materials to the front of the cell, enabling faster movement and repair. Discovered by chance and confirmed with advanced imaging, this system challenges decades of textbook biology. It may also reveal why some cancer cells spread so rapidly. Wed, 01 Apr 2026 06:32:34 EDT https://www.sciencedaily.com/releases/2026/03/260331001102.htm https://www.sciencedaily.com/releases/2026/03/260331001054.htm A breakthrough urine test could dramatically speed up how doctors treat urinary tract infections, identifying the right antibiotic in under six hours instead of waiting days. By testing directly from urine—skipping the usual lab culturing step—the method quickly shows which drugs stop bacterial growth and which don’t. In trials involving hundreds of patient samples, the test proved highly accurate, matching standard methods in over 96% of cases. Tue, 31 Mar 2026 01:45:05 EDT https://www.sciencedaily.com/releases/2026/03/260331001054.htm https://www.sciencedaily.com/releases/2026/03/260330084511.htm A major analysis of nearly 10,000 patients shows that simple, non-drug treatments like knee braces, hydrotherapy, and exercise can significantly ease knee osteoarthritis symptoms. These approaches not only reduce pain and improve mobility, but also avoid the risks tied to common medications. The findings suggest that low-cost, accessible therapies could play a bigger role in how doctors treat arthritis in the future. Mon, 30 Mar 2026 08:52:03 EDT https://www.sciencedaily.com/releases/2026/03/260330084511.htm https://www.sciencedaily.com/releases/2026/03/260330001131.htm A large U.S. study reveals that more than a quarter of people with hard-to-treat high blood pressure may have an overlooked hormone problem. Elevated cortisol—often linked to stress—was found in 27% of these patients, far higher than expected. This hidden condition could explain why standard medications fail. The discovery could lead to new testing and treatments that finally help bring blood pressure under control. Mon, 30 Mar 2026 03:50:56 EDT https://www.sciencedaily.com/releases/2026/03/260330001131.htm https://www.sciencedaily.com/releases/2026/03/260328043558.htm Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off switch” that mimics morphine’s benefits but skips its dangerous side effects. In early tests, it delivered lasting relief without affecting normal sensations. The discovery could mark a major step toward safer, non-addictive pain treatments. Sat, 28 Mar 2026 20:57:04 EDT https://www.sciencedaily.com/releases/2026/03/260328043558.htm https://www.sciencedaily.com/releases/2026/03/260328043556.htm After a stroke, the brain may do something surprisingly hopeful—it can “refresh” parts of itself. Researchers analyzing brain scans from over 500 stroke survivors found that while the damaged side of the brain appears to age faster, the opposite, unaffected side can actually look younger. This unexpected shift seems to reflect the brain’s effort to rewire itself, strengthening healthy regions to compensate for lost function. Sun, 29 Mar 2026 06:34:17 EDT https://www.sciencedaily.com/releases/2026/03/260328043556.htm https://www.sciencedaily.com/releases/2026/03/260328043554.htm A major new U.S. cholesterol guideline is shifting the focus toward earlier, more personalized prevention of heart disease. It urges people to start screening sooner—sometimes even in childhood—and highlights the importance of tracking not just LDL (“bad”) cholesterol but also genetic risk factors like lipoprotein(a). A new, more advanced risk calculator now uses broader health data to better predict heart attack and stroke risk over decades. Sun, 29 Mar 2026 05:43:08 EDT https://www.sciencedaily.com/releases/2026/03/260328043554.htm https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260326011452.htm Deepfake X-rays created by AI are now convincing enough to fool both doctors and AI models. In tests, radiologists had limited success identifying fake images, especially when they didn’t know they were being shown. This opens the door to risks like fraudulent medical claims and tampered diagnoses. Experts say stronger safeguards and detection tools are critical as the technology advances. Thu, 26 Mar 2026 06:42:12 EDT https://www.sciencedaily.com/releases/2026/03/260326011452.htm https://www.sciencedaily.com/releases/2026/03/260325055441.htm A major discovery reveals that metformin works not just in the body, but in the brain. By switching off a key protein and activating specific neurons, the drug lowers blood sugar through a previously hidden pathway, opening new doors for diabetes treatment. Wed, 25 Mar 2026 06:47:31 EDT https://www.sciencedaily.com/releases/2026/03/260325055441.htm https://www.sciencedaily.com/releases/2026/03/260325005910.htm When temperatures plunge, the risk to your heart rises dramatically. A large U.S. study shows cold weather is linked to far more cardiovascular deaths than heat, accounting for tens of thousands of extra deaths each year. Scientists found the safest temperature sits around 74°F, with danger increasing as conditions get colder—or hotter. As more people live with chronic illnesses, the threat from extreme cold may only intensify. Wed, 25 Mar 2026 21:11:55 EDT https://www.sciencedaily.com/releases/2026/03/260325005910.htm https://www.sciencedaily.com/releases/2026/03/260324080203.htm Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available vitamin could become a powerful new treatment. Tue, 24 Mar 2026 08:09:15 EDT https://www.sciencedaily.com/releases/2026/03/260324080203.htm https://www.sciencedaily.com/releases/2026/03/260324024302.htm For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections. Now, researchers at Kumamoto University have developed a clever workaround using a tiny peptide that helps insulin slip through the intestinal wall. Tue, 24 Mar 2026 04:08:11 EDT https://www.sciencedaily.com/releases/2026/03/260324024302.htm https://www.sciencedaily.com/releases/2026/03/260324024251.htm Researchers have visualized atoms in motion just before a radiation-driven decay process occurs, revealing a surprisingly dynamic scene. Instead of remaining fixed, the atoms roam and rearrange, directly influencing how and when the decay unfolds. This “atomic movie” shows that structure and motion play a central role in radiation damage mechanisms. The findings could improve our understanding of how harmful radiation affects biological matter. Tue, 24 Mar 2026 23:53:24 EDT https://www.sciencedaily.com/releases/2026/03/260324024251.htm https://www.sciencedaily.com/releases/2026/03/260323005545.htm A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that without this enzyme, liver cells grow abnormally large and accumulate genetic damage, leading to inflammation, scarring, and eventually tumors, especially with age. While inhibiting Caspase-2 may offer short-term benefits, such as reducing fatty liver disease, the long-term consequences appear dangerous. Mon, 23 Mar 2026 03:13:52 EDT https://www.sciencedaily.com/releases/2026/03/260323005545.htm https://www.sciencedaily.com/releases/2026/03/260323005542.htm A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots. Mon, 23 Mar 2026 22:28:06 EDT https://www.sciencedaily.com/releases/2026/03/260323005542.htm https://www.sciencedaily.com/releases/2026/03/260322020302.htm Scientists have uncovered a surprising brain-based trigger for high blood pressure, tracing it to a small region in the brainstem that normally controls breathing. This area, which kicks in during forceful exhalations like coughing, laughing, or exercise, also appears to activate nerves that tighten blood vessels—raising blood pressure. When researchers switched off this region in experiments, blood pressure dropped back to normal, suggesting it plays a direct role in hypertension. Sun, 22 Mar 2026 23:30:22 EDT https://www.sciencedaily.com/releases/2026/03/260322020302.htm https://www.sciencedaily.com/releases/2026/03/260321012638.htm Antibiotics are accumulating in a major Brazilian river, especially during the dry season when pollution becomes more concentrated. Scientists even detected a banned drug inside fish sold for food, raising concerns about human exposure. A common aquatic plant showed promise in removing these chemicals from water—but it also altered how fish absorb them, creating unexpected risks. Sat, 21 Mar 2026 20:48:07 EDT https://www.sciencedaily.com/releases/2026/03/260321012638.htm https://www.sciencedaily.com/releases/2026/03/260319074604.htm Eating large amounts of ultra-processed foods like chips, frozen meals, sugary drinks, and packaged snacks may significantly raise the risk of serious heart problems. In a major U.S. study, people consuming around nine servings per day had a 67% higher risk of heart attacks, strokes, or death from heart disease compared to those eating about one serving. The risk didn’t just jump at high levels either. Each additional daily serving increased the likelihood of these events by more than 5%, even after accounting for calories, overall diet quality, and common health conditions. Thu, 19 Mar 2026 20:54:23 EDT https://www.sciencedaily.com/releases/2026/03/260319074604.htm https://www.sciencedaily.com/releases/2026/03/260319044648.htm Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who discontinue these drugs manage to keep the weight off—or even continue losing—by restarting treatment, switching medications, or adopting lifestyle changes. While earlier clinical trials suggested rapid weight regain, this new evidence paints a more hopeful picture. Thu, 19 Mar 2026 23:08:04 EDT https://www.sciencedaily.com/releases/2026/03/260319044648.htm https://www.sciencedaily.com/releases/2026/03/260318033134.htm A risky but often lifesaving surgery that removes damaged parts of the small intestine can leave patients facing a new threat: serious liver damage with no available treatment. Now, scientists have developed a promising compound that works directly in the gut to shield the liver and improve how the body absorbs nutrients. In mouse studies, the drug boosted weight gain, reduced harmful liver scarring, and avoided side effects by staying confined to the intestines. Wed, 18 Mar 2026 03:31:34 EDT https://www.sciencedaily.com/releases/2026/03/260318033134.htm https://www.sciencedaily.com/releases/2026/03/260317064507.htm A critically ill 33-year-old man survived an almost unimaginable scenario—living for 48 hours without lungs—thanks to a groundbreaking surgical approach. After a severe flu-triggered infection destroyed his lungs and caused multiple organ failure, doctors removed both lungs entirely to stop the spread of infection. In their place, they used a specially engineered “artificial lung” system to oxygenate his blood and keep his body functioning while he stabilized. Wed, 18 Mar 2026 04:15:21 EDT https://www.sciencedaily.com/releases/2026/03/260317064507.htm https://www.sciencedaily.com/releases/2026/03/260317064444.htm Early life stress may set the stage for long-term digestive problems by disrupting the gut-brain connection. Studies in both mice and thousands of children found links to symptoms like pain, constipation, and IBS. Scientists discovered that different biological pathways control different gut issues, hinting at more personalized treatments in the future. The research also highlights how a child’s early environment can have lasting physical effects—not just emotional ones. Tue, 17 Mar 2026 22:08:54 EDT https://www.sciencedaily.com/releases/2026/03/260317064444.htm https://www.sciencedaily.com/releases/2026/03/260315004359.htm Researchers have developed a tiny antibody that can find a common cancer protein and make tumors light up during PET scans. In tests with mice, tumors containing the protein EphA2 glowed clearly when the antibody was used. This could help doctors quickly identify patients who may benefit from new targeted cancer treatments. The method may also provide a faster and less invasive alternative to traditional testing. Mon, 16 Mar 2026 01:04:50 EDT https://www.sciencedaily.com/releases/2026/03/260315004359.htm https://www.sciencedaily.com/releases/2026/03/260315001845.htm A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin D3 did not make COVID-19 infections less severe or reduce hospital visits. However, the study uncovered a subtle but intriguing signal suggesting that people who consistently took vitamin D supplements might be slightly less likely to develop long COVID symptoms weeks after infection. Sun, 15 Mar 2026 05:54:54 EDT https://www.sciencedaily.com/releases/2026/03/260315001845.htm https://www.sciencedaily.com/releases/2026/03/260313062539.htm Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on toxic chemicals and harsh conditions, the new approach uses an LED lamp to create essential carbon–carbon bonds under mild conditions. This could make drug discovery faster and more environmentally friendly. The breakthrough was uncovered unexpectedly during a failed laboratory experiment. Sat, 14 Mar 2026 01:56:59 EDT https://www.sciencedaily.com/releases/2026/03/260313062539.htm https://www.sciencedaily.com/releases/2026/03/260313002640.htm Researchers have identified two gut bacteria that can produce serotonin, a key chemical that regulates bowel movements. In experiments with mice lacking serotonin, the microbes boosted serotonin levels, increased nerve cells in the colon, and normalized intestinal movement. The study also found that people with IBS have lower levels of one of these bacteria. The discovery suggests gut microbes could become a powerful new target for treating digestive disorders. Fri, 13 Mar 2026 23:28:29 EDT https://www.sciencedaily.com/releases/2026/03/260313002640.htm https://www.sciencedaily.com/releases/2026/03/260312020107.htm Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive disorder produced more energy molecules at rest but had trouble increasing energy production when needed. Scientists believe this imbalance may contribute to symptoms such as fatigue and low motivation. The finding could help pave the way for earlier diagnosis and more personalized treatments. Thu, 12 Mar 2026 07:09:13 EDT https://www.sciencedaily.com/releases/2026/03/260312020107.htm https://www.sciencedaily.com/releases/2026/03/260311004824.htm A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers found that even a very small dose of EVG7 was highly effective at clearing the infection and preventing it from coming back. Unlike many current antibiotics, which wipe out large portions of the gut microbiome, EVG7 appears to spare beneficial bacteria that naturally help keep C. difficile in check. Wed, 11 Mar 2026 20:19:45 EDT https://www.sciencedaily.com/releases/2026/03/260311004824.htm https://www.sciencedaily.com/releases/2026/03/260309225222.htm Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people with bladder cancer who are also colorblind have a 52% higher mortality rate over 20 years compared to those with normal vision. The likely reason: many people with color vision deficiency struggle to see red, making it harder to notice blood in urine, the most common early sign of bladder cancer. Tue, 10 Mar 2026 01:49:43 EDT https://www.sciencedaily.com/releases/2026/03/260309225222.htm https://www.sciencedaily.com/releases/2026/03/260309225154.htm A new analysis of more than 422,000 patients reveals a stark Alzheimer’s care gap between Maryland’s urban and rural communities. Rural regions often lack hospitals and dementia specialists, forcing older patients to travel farther for diagnosis and treatment. Researchers found areas with high Alzheimer’s death rates but surprisingly low diagnosis rates, suggesting many cases may never be identified. Mon, 09 Mar 2026 22:51:54 EDT https://www.sciencedaily.com/releases/2026/03/260309225154.htm https://www.sciencedaily.com/releases/2026/03/260309225152.htm Cancer often begins when the genetic instructions that guide our cells become scrambled, allowing cells to grow uncontrollably. Now, scientists at EMBL have developed an AI-powered system called MAGIC that can automatically spot and tag cells showing early signs of chromosomal trouble—tiny DNA-filled structures known as micronuclei that are linked to future cancer development. Tue, 10 Mar 2026 19:12:39 EDT https://www.sciencedaily.com/releases/2026/03/260309225152.htm https://www.sciencedaily.com/releases/2026/03/260307213244.htm A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable. Sun, 08 Mar 2026 16:45:01 EDT https://www.sciencedaily.com/releases/2026/03/260307213244.htm https://www.sciencedaily.com/releases/2026/03/260307213234.htm A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression. Researchers tracked changes in a critical brain receptor that helps neurons communicate and found that ketamine reshapes its activity in specific brain regions tied to mood and reward. These shifts strongly matched improvements in patients’ symptoms. The findings could help scientists develop better ways to predict who will benefit from ketamine therapy. Sun, 08 Mar 2026 19:40:58 EDT https://www.sciencedaily.com/releases/2026/03/260307213234.htm https://www.sciencedaily.com/releases/2026/03/260306224238.htm Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to process fat, leading to inflammation, scarring, and potentially cirrhosis. The discovery began with a father and daughter who had the disease without typical risk factors. Large-scale genomic data suggests similar rare variants may quietly contribute to the disease in many more people. Sat, 07 Mar 2026 06:04:29 EST https://www.sciencedaily.com/releases/2026/03/260306224238.htm